Yahoo
OTC Markets OTCPK - Delayed Quote USD

Demant A/S (WILYY)

27.25 +0.65 (+2.44%)
As of October 29 at 4:00:00 PM EDT. Market Open.
Chart Range Bar
Loading chart for WILYY
  • Previous Close 26.60
  • Open 27.50
  • Bid 26.46 x 10000
  • Ask 28.60 x 10000
  • Day's Range 27.50 - 27.50
  • 52 Week Range 13.45 - 28.10
  • Volume 100
  • Avg. Volume 423
  • Market Cap (intraday) 11.494B
  • Beta (5Y Monthly) 0.70
  • PE Ratio (TTM) 30.28
  • EPS (TTM) 0.90
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Zacks Rating Bullish

Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

www.demant.com

26,616

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index (^OMXC25) .

YTD Return

WILYY
66.26%
OMX Copenhagen 25 Index (^OMXC25)
8.24%

1-Year Return

WILYY
45.96%
OMX Copenhagen 25 Index (^OMXC25)
16.87%

3-Year Return

WILYY
32.93%
OMX Copenhagen 25 Index (^OMXC25)
23.23%

5-Year Return

WILYY
11.54%
OMX Copenhagen 25 Index (^OMXC25)
0.16%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 6.67B
Earnings --
Profit Margin 0.00%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
2B
4B
6B
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.55%

  • Return on Assets (ttm)

    7.29%

  • Return on Equity (ttm)

    23.30%

  • Revenue (ttm)

    24.63B

  • Net Income Avi to Common (ttm)

    2.42B

  • Diluted EPS (ttm)

    0.90

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.5B

  • Total Debt/Equity (mrq)

    179.22%

  • Levered Free Cash Flow (ttm)

    3.76B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: